YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells

Shock

Volumn 30, Issue 3, 2008, Pages 274-279

  Liu, Yi Nan ^a   Pan, Shiow Lin ^a   Peng, Chieh Yu ^a   Huang, Der Yi ^a   Guh, Jih Hwa ^b   Kuo, Sheng Chu ^c   Lee, Fang Yu ^d   Teng, Che Ming ^a,b  

^a Phamacological Institute   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d Yung Shin Pharmaceutical Industry Co Ltd   (Taiwan)

Author keywords

Heat shock protein 70; Heat shock transcription factor 1; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIOXIDANT; CYCLIC GMP; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTER; GENE TRANSLOCATION; MALE; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELL NUCLEUS; DNA-BINDING PROTEINS; ENZYME ACTIVATORS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HSP70 HEAT-SHOCK PROTEINS; INDAZOLES; LIPOPROTEINS, LDL; MALE; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; TRANSCRIPTION FACTORS;

EID: 52649137743     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318162c63a     Document Type: Article

References (35)

1. Garcia DT: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 353:429-430, 2005.
2. Liuzzo G: Atherosclerosis: an inflammatory disease. Rays. 26:221-230, 2001.
3. Aikawa M, Libby P: The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 13:125-138, 2004.
4. Loidl A, Claus R, Ingolic E, Deigner HP, Hermetter A: Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells. Biochim Biophys Acta 1690:150-158, 2004.
5. Zhu J, Quyyumi AA, Wu H, Csako G, Rott D, Zalles-Ganley A, Ogunmakinwa J, Halcox J, Epstein SE: Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vase Biol 23:1055-1059, 2003.
6. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH: Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95:1446-1456, 1995.
7. Plumier JC, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G, Pagoulatos GN: Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 95: 1854-1860, 1995.
8. Mehta TA, Greenman J, Ettelaie C, Venkatasubramaniam A, Chetter IC, McCollum PT: Heat shock proteins in vascular disease - a review. Eur J Vase Endovasc Surg 29:395-402, 2005.
9. Pockley AG: Heat shock proteins, inflammation, and cardiovascular disease. Circulation 105:1012-1017, 2002.
10. Hightower LE: Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66:191-197, 1991.
11. Beere HM: "The stress of dying": the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 117:2641-2651, 2004.
12. Xu Q: Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vase Biol 22:1547-1559, 2002.
13. Christians ES, Yan LJ, Benjamin IJ: Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury. Crit Care Med 30:S43-S50, 2002.
14. Morimoto RI: Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12:3788-3796, 1998.
15. Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM: YC-1, a novel activator of platelet guanylate cyclase. Blood 84:4226-4233, 1994.
16. Tulis DA, Bohl Masters KS, Lipke EA, Schiesser RL, Evans AJ, Peyton KJ, Durante W, West JL, Schafer AI: YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. Bioehem Biophys Res Commun 291:1014-1021, 2002.
17. Garthwaite G, Goodwin DA, Neale S, Riddall D, Garthwaite J: Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition. Mol Pharmacol 61:97-104, 2002.
18. Liu YN, Pan SL, Peng CY, Guh JH, Huang DM, Chang YL, Lin CH, Pai HC, Kuo SC, Lee FY, et al.: YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9. J Pharmacol Exp Ther 316:35-41, 2006.
19. Pan SL, Guh JH, Huang YW, Chang YL, Chang CY, Huang LJ, Kuo SC, Teng CM: Inhibition of Ras-mediated cell proliferation by benzyloxybenzaldehyde. J Biomed Sci 9:622-630, 2002.
20. Chavakis E, Dernbach E, Hermann C, Mondorf UF, Zeiher AM, Dimmeler S: Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 103:2102-2107, 2001.
21. Xu Q, Hu Y, Kleindienst R, Wick G: Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. J Clin Invest 100:1089-1097, 1997.
22. Yu SM, Hung LM, Lin CC: cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation 95:1269-1277, 1997.
23. Xu Z, Ji X, Boysen PG: Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am J Physiol Heart Circ Physiol 286:H1433-H1440, 2004.
24. Martindale JL, Holbrook NJ: Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1-15, 2002.
25. Jagadeeswaran R, Jagadeeswaran S, Bindokas VP, Salgia R: Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 292:L1488-L1494, 2007.
26. Rappeneau S, Baeza-Squiban A, Jeulin C, Marano F: Protection from cytotoxic effects induced by the nitrogen mustard mechlorethamine on human bronchial epithelial cells in vitro. Toxicol Sci 54:212-221, 2000.
27. DeMeester SL, Buchman TG, Qiu Y, Dunnigan K, Hotchkiss RS, Karl IE, Cobb JP: Pyrrolidine dithiocarbamate activates the heat shock response and thereby induces apoptosis in primed endothelial cells. Shock 10:1-6, 1998.
28. Johnson AD, Berberian PA, Tytell M, Bond MG: Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival. Arterioscler Thromb Vasc Biol 15:27-36, 1995.
29. Yamamoto K, Sarukawa M, Ito T, Aoki H, Ichida M, Shimada K: An antiulcer drug, geranylgeranylacetone, suppresses inducible nitric oxide synthase in cultured vascular smooth muscle cells. J Hypertens 23:1847-1853, 2005.
30. Huang YT, Pan SL, Guh JH, Chang YL, Lee FY, Kuo SC, Teng CM: YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells. Mol Cancer Ther 4:1628-1635, 2005.
31. Wang SW, Pan SL, Guh JH, Chen HL, Huang DM, Chang YL, Kuo SC, Lee FY, Teng CM: YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells. J Pharmacol Exp Ther 312: 917-925, 2005.
32. Morimoto RI, Santoro MG: Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 16: 833-838, 1998.
33. Kim HP, Wang X, Zhang J, Suh GY, Benjamin IJ, Ryter SW, Choi AM: Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J Immunol 175: 2622-2629, 2005.
34. Chun YS, Yeo EJ, Park JW: Versatile pharmacological actions of YC-1: anti-platelet to anticancer. Cancer Lett 207:1-7, 2004.
35. Kume N, Kita T: Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture. Circ Res 94:269-270, 2004.